Reliability of 1,9-dimethylmethylene blue tests in comparison to agarose gel electrophoresis for quantification of urinary glycosaminoglycans

Clinica Chimica Acta

Volumn 378, Issue 1-2, 2007, Pages 206-215

  de Lima, Cilene R ^a   Baccarin, Raquel Y A ^b   Michelacci, Yara M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Agarose gel electrophoresis; DMB assay; Glycosaminoglycan; Urine

Indexed keywords

1,9 DIMETHYLMETHYLENE BLUE; CITRIC ACID; GLYCOSAMINOGLYCAN; METHYLENE BLUE; PHOSPHATE; SULFATE; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ARTICLE; BODY FLUID; CAT; CONTROLLED STUDY; DENSITOMETRY; HORSE; HUMAN; INTERMETHOD COMPARISON; ION EXCHANGE; ION EXCHANGE CHROMATOGRAPHY; KIDNEY CONCENTRATING CAPACITY; MAMMAL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; URINALYSIS;

ANIMALS; CREATININE; DENSITOMETRY; DOGS; ELECTROPHORESIS, AGAR GEL; GLYCOSAMINOGLYCANS; GOATS; HORSES; METHYLENE BLUE; SHEEP;

EQUIDAE; MAMMALIA;

EID: 33846914886     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.11.025     Document Type: Article

References (45)

1. Kjéllen L., and Lindahl U. Proteoglycans: structure and interactions. Ann Rev Biochem 60 (1991) 443-475
2. Toma L., Dietrich C.P., and Nader H.B. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes. Lab Invest 75 (1996) 771-781
3. Wraith J.E., Clarke L.A., Beck M., et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-l-iduronidase (Laronidase). J Pediatr 144 (2004) 581-588
4. Harmatz P., Giugliani R., Schwartz I., et al. Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr 148 (2006) 533-539
5. Muenzer J., Wraith J.E., Beck M., et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 8 (2006) 465-473
6. Friso A., Tomanin R., Alba S., et al. Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts. J Gene Med 7 (2005) 1482-1491
7. Martins J.R.M., Gadelha M.E.C., Fonseca S.M., et al. Patients with head and neck tumors excrete a chondroitin sulfate with a low degree of sulfation: a new tool for diagnosis and follow-up of cancer therapy. Otolaryngol Head Neck Surg 122 (2000) 115-118
8. Akçay T., and Konokoglu D. Glycosaminoglycan excretion in interstitial cystitis. Int Urol Nephrol 31 (1999) 431-435
9. Pereira D.A., Aguiar J.A.K., Hagiwara M.K., and Michelacci Y.M. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome. Bba-Gen Subjects 1672 (2004) 1-11
10. Michelacci Y.M., Glashan R.Q., and Schor N. Urinary excretion of glycosaminoglycans in normal and stone forming subjects. Kidney Int 36 (1989) 1022-1028
11. Cadaval R.A.M., Kohlman O., and Michelacci Y.M. Urinary excretion of glycosaminoglycans and albumin in experimental diabetes mellitus. Glycobiology 10 (2000) 185-192
12. De Muro P., Faedda R., Satta A., et al. Urinary glycosaminoglycan composition in chronic glomerulonephritis. J Nephrol 18 (2005) 154-160
13. Michelacci Y.M., Cadaval R.A.M., Rovigatti R.M., and Kohlman O. Renal and urinary glycosaminoglycans in an experimental model of chronic renal failure in rats. Exp Nephrol 9 (2001) 40-48
14. de Lima C.R., Aguiar J.A.K., and Michelacci Y.M. Reduced urinary excretion of sulfated polysaccharides in diabetic rats. Bba-Mol Basis Dis 1741 (2005) 30-41
15. Vieira F.A.C., Baccarin R.Y.A., Aguiar J.A.K., and Michelacci Y.M. Urinary excretion of glycosaminoglycans in horses: changes with age, training and osteoarthritis. J Equine Vet Sci 25 (2005) 387-400
16. Martins J.R., Furlanetto R.P., Oliveira L.M., et al. Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf ) 60 (2004) 726-733
17. Kleine T.O., and Henrich N.C. Turbidimetric Alcian Blue test for the determination of glycosaminoglycan degradation products in human-urine. Fresenius Z Anal Chem 320 (1985) 720-721
18. Berry H. Screening for mucopolysaccharide disorders with the Berry spot test. Clin Biochem 20 (1987) 365-371
19. Crawley A., Ramsay S.L., Byers S., Hopwood J.J., and Meikle P.J. Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry. Pediatr Res 55 (2004) 585-591
20. Di Ferrante N.M. The measurement of urinary mucopolysaccharides. Anal Biochem 21 (1967) 98-106
21. Whiteman P. Quantitative-determination of glycosaminoglycans in urine with Alcian Blue 8gx. Biochem J 131 (1973) 351-357
22. Farndale R.W., Sayers C.A., and Barrett A.J. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9 (1982) 247-248
23. de Jong J.G.N., Wevers R.A., Laarakkers C., and Poorthuis B.J.H.M. Dimethylmethylene Blue-based spectrophotometry of glycosaminoglycans in untreated urine - a rapid screening-procedure for mucopolysaccharidoses. Clin Chem 35 (1989) 1472-1477
24. Farndale R.W., Buttle D.J., and Barrett A.J. Improved quantitation and discrimination of sulfated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883 (1986) 173-177
25. de Jong J.G.N., Wevers R.A., and Liebrandvansambeek R. Measuring urinary glycosaminoglycans in the presence of protein - an improved screening-procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem 38 (1992) 803-807
26. Dietrich C.P., Mcduffie N.M., and Sampaio L.O. Identification of acidic mucopolysaccharides by agarose-gel electrophoresis. J Chromatogr 130 (1977) 299-304
27. Dietrich C.P., and Nader H.B. Fractionation and properties of four heparitin sulfates from beef lung tissue. Isolation and partial characterization of a homogeneous species of heparitin sulfate. Biochim Biophys Acta 343 (1974) 34-44
28. Soriano E.S., Campos M.S.Q., Aguiar J.A.K., and Michelacci Y.M. Effect of epithelial debridement on human cornea proteoglycans. Braz J Med Biol Res 34 (2001) 325-331
29. Michelacci Y.M., and Horton D.S.P.Q. Proteoglycans from the cartilage of young hammerhead shark Sphyrna lewini. Comp Biochem Physiol B 92 (1989) 651-658
30. Nader H.B., Porcionatto M.A., Tersariol I.L., et al. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. J Biol Chem 265 (1990) 16807-16813
31. Aguiar J.A.K., Lima C.R., Berto A.G.A., and Michelacci Y.M. An improved methodology to produce Flavobacterium heparinum chondroitinases, important instruments for diagnosis of diseases. Biotechnol Appl Bioc 37 (2003) 115-127
32. Alves M.L.M., Straus A.H., Takahashi H.K., and Michelacci Y.M. Production and characterization of monoclonal-antibodies to shark cartilage proteoglycan. Braz J Med Biol Res 27 (1994) 2103-2108
33. Nader H.B., and Dietrich C.P. Determination of sulfate after chromatography and Toluidine Blue complex-formation. Anal Biochem 78 (1977) 112-118
34. Spector T. Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein. Anal Biochem 86 (1978) 142-146
35. Dial S.M., Byrne T., Haskins M., et al. Urine glycosaminoglycan concentrations in mucopolysaccharidosis VI-affected cats following bone marrow transplantation or leukocyte infusion. Clin Chim Acta 263 (1997) 1-14
36. Sarica K., Türkölmez K., Soygür T., et al. Evaluation of urinary glycosaminoglycan excretion in patients with renal cell carcinoma. Eur Urol 31 (1997) 54-57
37. Uehling D.T., Kelley E., Hopkins W.J., and Balish E. Urinary glycosaminoglycan levels following induced cystitis in monkeys. J Urol 139 (1988) 1103-1105
38. Mabe P., Valiente A., Soto V., Cornejo V., and Raimann E. Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests. Clin Chim Acta 345 (2004) 135-140
39. Byers S., Rozaklis T., Brumfield L.K., Ranieri E., and Hopwood J.J. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Mol Genet Metab 65 (1998) 282-290
40. Hurst R.E., Settine J.M., and Lorincz A.E. A method for the quantitative determination of urinary glycosaminoglycans. Clin Chim Acta 70 (1976) 427-432
41. Fellstrom B., Danielson B.G., Lind E., Ljunghall S., and Wikstrom B. Enzymatic determination of urinary chondroitin sulfate - applications in renal stone disease and acromegaly. Eur J Clin Invest 16 (1986) 292-296
42. Fellstrom B., Danielson B.G., Ljunghall S., and Wikstrom B. Crystal inhibition- the effects of polyanions on calcium-oxalate crystal-growth. Clin Chim Acta 158 (1986) 229-235
43. Dietrich C.P., Nader H.B., and Mourao P.A.S. Differentiation of Hunters and Hurlers syndromes by analysis of excreted mucopolysaccharides. Biochem Med Metab Biol 8 (1973) 371-379
44. de Jong J.G.N., Heijs W.M.J., and Wevers R.A. Mucopolysaccharidoses screening - dimethylmethylene blue versus Alcian Blue. Ann Clin Biochem 31 (1994) 267-271
45. Michelacci Y.M., and Dietrich C.P. Comparative study between a chondroitinase B and a chondroitinase AC from Flavobacterium heparinum - isolation of a chondroitinase AC-susceptible dodecasaccharide from chondroitin sulfate B. Biochem J 151 (1975) 121-129